Sign in
4

Changes in Ownership

PROTHENA CORP PUBLIC LTD CO Filed Acc 0001140361-23-028870

Chief Scientific Officer sold 19,000 shares at an average $71.06 ($1,350,224)

  • Chief Scientific Officer acquired 19,000 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Zago Wagner M. Chief Scientific Officer 2023-06-07 Option exercise 10b5-1 +15,000 $29.81 $447,150 15,000 D: show line 1 in the form
Zago Wagner M. Chief Scientific Officer 2023-06-07 Option exercise 10b5-1 +4,000 $12.15 $48,600 19,000 D: show line 2 in the form
Zago Wagner M. Chief Scientific Officer 2023-06-07 Sale 10b5-1 −2,943 $70.02 $206,061 16,057 D: show line 3 in the form
Zago Wagner M. Chief Scientific Officer 2023-06-07 Sale 10b5-1 −12,004 $70.99 $852,181 4,053 D: show line 4 in the form
Zago Wagner M. Chief Scientific Officer 2023-06-07 Sale 10b5-1 −3,759 $71.96 $270,479 294 D: show line 5 in the form
Zago Wagner M. Chief Scientific Officer 2023-06-07 Sale 10b5-1 −294 $73.14 $21,503 0 D: show line 6 in the form
Open-market sales · 19,000 sh · avg $71.06 · $1,350,224

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
Zago Wagner M. Chief Scientific Officer 2023-06-07 Option exercise · Stock Option (Right to Buy) 10b5-1 −15,000 0 D: show line 7 in the form
Zago Wagner M. Chief Scientific Officer 2023-06-07 Option exercise · Stock Option (Right to Buy) 10b5-1 −4,000 66,000 D: show line 8 in the form
Loading xslF345X04/form4.xml…